4//SEC Filing
Wasoff Evan L 4
Accession 0001214659-18-006692
CIK 0001625288other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 1:59 PM ET
Size
7.4 KB
Accession
0001214659-18-006692
Insider Transaction Report
Form 4
Wasoff Evan L
Chief Financial Officer
Transactions
- Award
Stock option - right to buy
2018-10-26+200,000→ 200,000 totalExercise: $0.66From: 2018-10-26Exp: 2025-10-26→ Common Stock (200,000 underlying)
Holdings
- 1,000,000
Common Stock
- 420,000
Stock option - right to buy
Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ Common Stock (420,000 underlying)
Footnotes (2)
- [F1]Granted under the Company's 2018 Equity Incentive Plan.
- [F2]35,000 options vested immediately, with the remainder vesting monthly over the next 11 months beginning August 1, 2018.
Documents
Issuer
NEXIEN BIOPHARMA, INC.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001719738
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 1:59 PM ET
- Size
- 7.4 KB